Cencora director buys 4,000 shares in open market
Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of 4,000 shares of Common Stock on 2026-05-28 at an average price of $266.26 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of 4,000 shares of Common Stock on 2026-05-28 at an average price of $266.26 per share. Following this transaction, he directly owns 27,767 Cencora shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,000 | $266.26 | $1.07M |
Key Figures
Key Terms
open-market purchase financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cencora (COR) disclose in this Form 4?
What are Dermot Mark Durcan’s Cencora (COR) holdings after the transaction?
Was the Cencora (COR) insider transaction a buy or a sell?
Does this Cencora (COR) Form 4 involve any stock options or derivatives?
AI-generated analysis. How Rhea-AI works. Not financial advice.